Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

  1. El-Dirany, R.
  2. Fernández-Rubio, C.
  3. Peña-Guerrero, J.
  4. Moreno, E.
  5. Larrea, E.
  6. Espuelas, S.
  7. Abdel-Sater, F.
  8. Brandenburg, K.
  9. Martínez-de-Tejada, G.
  10. Nguewa, P.
Journal:
Pharmaceutics

ISSN: 1999-4923

Year of publication: 2022

Volume: 14

Issue: 11

Type: Article

DOI: 10.3390/PHARMACEUTICS14112528 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals